T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Prelude Therapeutics
PRLD
$457M
| $743K | ﹤0.01% |
927,608
-48,539
| -5% | -$42K |
|
2102
Vitesse Energy
VTS
$685M
| $741K | ﹤0.01% |
33,501
+2,961
| +10% | +$64.9K |
|
|
PRSU
2103
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $741K | ﹤0.01% |
25,674
+1,448
| +6% | +$42.7K |
|
2104
Cimpress
CMPR
$2.4B
| $739K | ﹤0.01% |
15,712
+465
| +3% | +$20.3K |
|
2105
Reynolds Consumer Products
REYN
$5.53B
| $737K | ﹤0.01% |
34,370
+3,539
| +11% | +$80.1K |
|
|
KE
2106
Kimball Electronics
KE
$606M
| $735K | ﹤0.01% |
38,179
+573
| +2% | +$9.59K |
|
2107
Willdan Group
WLDN
$1.29B
| $734K | ﹤0.01% |
11,737
+855
| +8% | +$40.8K |
|
|
DHC
2108
Diversified Healthcare Trust
DHC
$2.02B
| $731K | ﹤0.01% |
203,976
+16,607
| +9% | +$47.9K |
|
2109
Revolve Group
RVLV
$1.69B
| $730K | ﹤0.01% |
36,408
+2,442
| +7% | +$49.4K |
|
|
CLDT
2110
Chatham Lodging
CLDT
$590M
| $728K | ﹤0.01% |
104,331
+7,092
| +7% | +$49.5K |
|
2111
Matrix Service
MTRX
$330M
| $722K | ﹤0.01% |
53,406
+374
| +0.7% | +$4.51K |
|
2112
Atlas Energy Solutions
AESI
$1.47B
| $719K | ﹤0.01% |
53,753
-2,980,182
| -98% | -$40.7M |
|
2113
Unitil
UTL
$984M
| $719K | ﹤0.01% |
13,783
+1,067
| +8% | +$59.2K |
|
2114
IHS Holding
IHS
$2.82B
| $717K | ﹤0.01% |
128,800
-48,600
| -27% | -$262K |
|
2115
Kosmos Energy
KOS
$1.51B
| $717K | ﹤0.01% |
416,681
-2,272,155
| -85% | -$4.11M |
|
2116
Xeris Biopharma Holdings
XERS
$1.55B
| $716K | ﹤0.01% |
153,271
-23,122
| -13% | -$106K |
|
2117
The RMR Group
RMR
$337M
| $713K | ﹤0.01% |
43,574
-218
| -0.5% | -$3.34K |
|
|
CTO
2118
CTO Realty Growth
CTO
$819M
| $711K | ﹤0.01% |
41,192
+2,135
| +5% | +$38.6K |
|
2119
Ingles Markets
IMKTA
$1.66B
| $711K | ﹤0.01% |
11,212
+959
| +9% | +$59.6K |
|
2120
Liberty Latin America Class C
LILAK
$1.67B
| $707K | ﹤0.01% |
124,946
+8,135
| +7% | +$39.8K |
|
2121
Merchants Bancorp
MBIN
$2.52B
| $706K | ﹤0.01% |
21,341
+4,752
| +29% | +$154K |
|
|
SHYF
2122
DELISTED
The Shyft Group
SHYF
| $706K | ﹤0.01% |
56,253
+17,032
| +43% | +$167K |
|
2123
Syndax Pharmaceuticals
SNDX
$1.77B
| $706K | ﹤0.01% |
75,404
+9,290
| +14% | +$102K |
|
2124
Standard Motor Products
SMP
$877M
| $705K | ﹤0.01% |
22,946
+1,388
| +6% | +$38.4K |
|
2125
Buckle
BKE
$2.33B
| $704K | ﹤0.01% |
15,514
+1,926
| +14% | +$76.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.